Tribeca Studios has launched a new incubator program, which aims to empower rising filmmakers to more earnestly portray diseases and health-related stories on-screen. Tribeca created the program with ...

Eli Lilly has developed artificial intelligence models that can help predict the behavior of potential drug candidates, based on the data the drugmaker has collected over the last two decades and at ...

Sept 9 (Reuters) - Drugmaker Eli Lilly (LLY.N), opens new tab said on Tuesday it is launching an artificial intelligence and machine learning platform that provides biotech companies access to drug ...

A federal appeals court on Thursday rejected Eli Lilly’s appeal of an $183.7 million judgment won by a whistleblowing lawyer and pharmacist who accused the drugmaker of defrauding Medicaid. The 7th ...

Lila Biologics, a startup that spun out of Nobel Laureate David Baker’s lab at the University of Washington, announced a collaboration with pharmaceutical giant Eli Lilly to develop therapies for ...

Eli Lilly saw notable developments in September, with the launch of Lilly TuneLab, an AI/ML platform designed to enhance drug discovery, showcasing the company's commitment to technological innovation ...

Sept 8 (Reuters) - Eli Lilly's (LLY.N), opens new tab approved blood cancer therapy Jaypirca helped delay progression of the disease in previously untreated patients in a late-stage study, advancing ...

I am bullish on Eli Lilly, despite recent underperformance and Orforglipron's clinical results falling short of high expectations. Eli Lilly's robust R&D, strong pipeline, and leadership in diabetes, ...

In the latest close session, Eli Lilly (LLY) was up +1.51% at $738.17. The stock outpaced the S&P 500's daily gain of 0.21%. Elsewhere, the Dow gained 0.25%, while the tech-heavy Nasdaq added 0.45%.

Eli Lilly Loses Appeal of $183.7 Million Medicaid Fraud Award By Jonathan Stempel (Reuters) - A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a ...

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...